Navigation Links
VaxGen Provides Financial Update Following the Filing of Its 10-Q for Second Quarter With SEC; Results Include $8.5 Million Charge in Respect of Manufacturing Plant Asset Impairment
Date:8/27/2008

h and equivalents and investment securities as of July 31st, 2008, or $38.5 million net of the Company's $8 million of outstanding convertible debt.

On August 25, 2008, VaxGen received a $1 million milestone payment from Emergent BioSolutions, Inc., the purchaser of the Company's recombinant anthrax vaccine development program and associated assets, related to the generation of non-clinical data demonstrating the immunopotency and improved stability of the vaccine candidate.

During the second and third quarters, VaxGen further reduced its staff and operating expenses to preserve capital as it seeks to identify a strategic transaction which can deliver shareholder value. As a result of these cost cutting efforts, VaxGen will terminate Piers Whitehead, Vice President of Corporate and Business Development as of August 31 2008.

"With our new Strategic Transaction Committee of the Board fully engaged, and given the status of the transaction process, and our business, the Company and Piers can now part ways," said James P. Panek. "Piers has made innumerable contributions to VaxGen since joining VaxGen in 2002. His strategic thinking, negotiating skills and breadth of experience have been of tremendous value to the Company. He will be missed."

VaxGen expects its average monthly cash burn to be approximately $750,000, excluding unusual items. Management considers "cash burn" to be a non-GAAP financial measure. A reconciliation to GAAP is not provided since we are unable to predict the occurrence of unusual items which could be material to the company's results of operations.

About VaxGen

VaxGen is a biopharmaceutical company based in South San Francisco, California. The company owns a state-of-the-art biopharmaceutical manufacturing facility with a 1,000-liter bioreactor that can be used to make cell culture or microbial biologic products. The facility is contained within leased premises. For more information, please visit the compa
'/>"/>

SOURCE VaxGen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement
2. VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven
3. VaxGen Restructures Following Termination of Proposed Merger
4. Study provides hope that some transplant patients could live free of antirejection drugs
5. Study provides hope that some transplant patients could live free of anti-rejection drugs
6. USAID Provides Additional Wildfire Assistance to Greece
7. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
8. New knock-out gene model provides molecular clues to breast cancer
9. PreMD Provides Update on 510(k) Application for PREVU(x) POC
10. SIV infection of natural hosts provides new insights into HIV disease complexity
11. Microarray provides 3 genomic guides to breast cancer treatment decisions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...E, Fla. -- A Florida State University College of M...covered an important new layer of regulation in th...er understanding of the way cancer begins. , Wan...t the College of Medicine, said the findings will ... could lead to the design of new drugs that kill c...
(Date:11/21/2008)... Nov. 21 The Providence ...nced that Craig A. Norris, the Company,s,Chief Op...,s Board of,Directors. Mr. Norris, appointment f...on of Steven I. Geringer and returns the board to ...mmittee of the Board. , Mr. Norris, age 41,...
(Date:11/21/2008)...one day lead to a novel technique to combat cancer...althDay News) -- Belgian researchers have discover...of sugar for food, and this might lead to new trea...urvive and proliferate, all cells in the body need...[glucose], a process that requires oxygen. Compare...
(Date:11/21/2008)...ders Intend To Vigorously Protect Investment And R...v. 21 Dr. Stephen Joffe...dment to their Schedule 13D with the U.S. Securiti...filed a 13D disclosing ownership of 11.4% of LCA-V...asikPlus fixed-site laser vision correction center...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7
...h a pound of cure.' -Henry de Bracton – A disea...cause the deepest anguish is preventable. It is no...entable. Sunday, 4 February 2007, is World Cancer ...ying the theme - “Today’s Children, Tomorrow’s Wor...
... loss of muscle tone in the body, which occurs dur...r or anger. Cataplexy is one of the symptoms of// ... asleep. In narcolepsy there are compulsive sleep...tible urge to sleep even in the most unlikely circ...
...nt sports in the world, has continued to grow in p...hildren participating in organized and// unorganiz... children at risk for injury. A study conducted by...d Policy (CIRP) at Columbus Children’s Hospital is...
...new weapon is being investigated.// Scientists ha...nt -oligo fructose, on obese human subjects. The...ural fiber seen in baby foods, cereals and yogurt ... on genetically obese lab rats. Reportedly, oligo...
Other Medicine News:Health News:'Cancer Prevention' - In Your Hands 2Health News:'Cancer Prevention' - In Your Hands 3Health News:Cataplexy During Status Cataplecticus Resembles REM Sleep 2Health News:Study Reveals 1.6 Million Pediatric Soccer Injuries 2
(Date:11/20/2008)...-FirstCall/ -- PAREXEL International Corporation (...al services provider, today announced that it has ...ry consulting and clinical research capabilities. ...has locations throughout five important biopharmac...de Argentina, Brazil, Chile, and Mexico. This expa...
(Date:11/19/2008)...chieve statistical significance , , ISELIN,...Corporation (Nasdaq: PARS ) today announced resu...l NanoEmulsion (NE) drug delivery technology formu... The multi-center, randomized, double-blinded, pl...ficacy of the Company,s 3% Diclofenac Diethanolami...
(Date:11/19/2008)...t from Roche- , , MONTVALE, N.J., Nov. 19 /...rp. (Nasdaq: MEMY ) today announced that it has ... of R3487/MEM 3454, its lead alpha-7 nicotinic rec...with schizophrenia (CIAS). The Company has random... a $5.0 million payment from its partner Roche. M...
(Date:11/18/2008)...Newswire-USNewswire/ -- Forty-two leading U. S. sc...tional forum to consider cutting-edge innovations ...al economy from outbreaks of dangerous zoonotic di... Among those innovations: , , , , ...le that detects highly contagious and dangerous zo...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 1Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 2Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 3Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 4Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 5iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers 8359 1iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers 8359 2iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers 8359 3Antibiotics May Not Cause Diarrheal Bacteria 27262 1Antibiotics May Not Cause Diarrheal Bacteria 27262 2Healthcare Resources Available in Difficult Times 27258 1Healthcare Resources Available in Difficult Times 27258 2Healthcare Resources Available in Difficult Times 27258 3
...Mass.--(BUSINESS WIRE)--Jun 8, 2007 - Archemix Cor... and developing,aptamers, announced the successful...r therapeutic, ARC1779. ARC1779 is designed to,sel...ation of,platelets by inhibiting the binding of vo...platelets. Activated vWF is scientifically,recogni...
...MARGIN: 0in 0in 0pt; LINE-HEIGHT: 150%; mso-hyphen...oneering nasal spray,could stop thousands of patie...t was reported today1 at the 10th Congress of,the ..., 7–9,June. The study investigated whether t... fast onset of pain relief and short,duration of e...
Other Medicine Technology:Archemix Announces Completion of Phase 1 Trial of ARC1779 2Archemix Announces Completion of Phase 1 Trial of ARC1779 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 2Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 4Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 5Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 6
Zeiss offers a full range of filter sets for a variety of applications.
Dust covers for a variety of Zeiss microscopes
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
...that offers you much more than you have ever expec...e impressed by the outstanding quality, and functi... work as easy and safe as possible thus increasin... more time for the observation. , Contrasting...
Medicine Products: